Financials data is unavailable for this security.
View more
Year on year ICU Medical Inc had revenues remain flat at 2.28bn, though the company grew net income from a loss of 74.29m to a smaller loss of 29.66m. A reduction in the cost of goods sold as a percentage of sales from 69.40% to 67.25% was a component in the net income growth despite flat revenues.
| Gross margin | 32.47% |
|---|---|
| Net profit margin | -3.07% |
| Operating margin | 0.33% |
| Return on assets | -1.62% |
|---|---|
| Return on equity | -3.41% |
| Return on investment | -1.83% |
More ▼
Cash flow in USDView more
In 2023, ICU Medical Inc increased its cash reserves by 21.76%, or 45.44m. The company earned 166.20m from its operations for a Cash Flow Margin of 7.36%. In addition the company used 87.95m on investing activities and also paid 35.98m in financing cash flows.
| Cash flow per share | 6.46 |
|---|---|
| Price/Cash flow per share | 27.53 |
| Book value per share | 83.43 |
|---|---|
| Tangible book value per share | -8.96 |
More ▼
Balance sheet in USDView more
| Current ratio | 2.41 |
|---|---|
| Quick ratio | 1.08 |
| Total debt/total equity | 0.7897 |
|---|---|
| Total debt/total capital | 0.4412 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 60.45%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -44.48 |
